Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules

Human epidermal growth factor receptor type 3 (HER3) is an emerging therapeutic target in several malignancies. To select potential responders to HER3-targeted therapy, radionuclide molecular imaging of HER3 expression using affibody molecules could be performed. Due to physiological expression of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinne, Sara S., Xu, Tianqi, Dahlsson Leitao, Charles, Ståhl, Stefan, Löfblom, John, Orlova, Anna, Tolmachev, Vladimir, Vorobyeva, Anzhelika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072899/
https://www.ncbi.nlm.nih.gov/pubmed/32075258
http://dx.doi.org/10.3390/ijms21041312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072899/
https://www.ncbi.nlm.nih.gov/pubmed/32075258
http://dx.doi.org/10.3390/ijms21041312

Ejemplares similares